MedPath

Efficacy and safety of the fixed combinations latanoprost/ timolol versus dorzolamide / timolol in patients with elevated intraocular pressure.

Not Applicable
Conditions
Primary open-angle glaucoma.
Glaucoma primary residual stage: capsular with pseudoexfoliation of lens . chronic simple . low-tension . pigmentary
Registration Number
IRCT201109047466N1
Lead Sponsor
Arak University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

1-Primary open angle gluacoma
Exclusion criteria:
1-Secondary open angle glaucoma
2-Narrow-angle glaucoma
3-Allergy to trial drug
4-Ophthalmic herpes zoster
5-Pregnancy and lactation
6-Dry eyes that require use of ophtalmic drops is 5 times or more per day

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease of intraocular pressure. Timepoint: In beginning of the study and the end of six weeks after treatment. Method of measurement: Goldmann Tonometry.
Secondary Outcome Measures
NameTimeMethod
Failure of treatment. Timepoint: End of treatment. Method of measurement: Goldmann Tonometry.;Drug side effects. Timepoint: During study. Method of measurement: Clinical evaluation.
© Copyright 2025. All Rights Reserved by MedPath